Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05087303 · ClinicalTrials.gov registry record · NA
Telemedicine for Children With Sickle Cell Disease
A NA study of Anemia, Sickle Cell, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05087303: Active NA study of Anemia, Sickle Cell, sponsored by Indiana University.
NCT05087303 is a NA study of Anemia, Sickle Cell that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 24 participants, below the 117-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05087303, a NA study of Anemia, Sickle Cell, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consumer) for use with children with SCD using caregiver input from our preliminary K12 work. Aim 2: Demonstrate the feasibility of the telemedicine models developed in Aim 1 as the models undergo successive stakeholder refinement during use in actual clinical care. Aim 3: Evaluate the effectiveness of the refined models from Aim 2 in a pre/post study by assessing (a) process of care measures, (b) provider satisfaction, (c) caregiver/patient-centered outcomes, and (d) clinical outcomes and healthcare utilization.
Primary Outcome
Failed appointments in Electronic Medical Record - no more than one failed appointment during pilot year.
Conditions Studied
Interventions
- OTHER Types of Telemedicine Delivery Models
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-11-23 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT05087303 still lists
NCT05087303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 117-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 1 intervention - of which Types of Telemedicine Delivery Models is the first listed.
NCT05087303 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05087303 about?
NCT05087303 is a clinical study titled "Telemedicine for Children With Sickle Cell Disease". The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consume...
What is the current status of trial NCT05087303?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2022-11-23. Estimated completion is 2026-04-30.
What conditions does trial NCT05087303 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
What interventions are being tested in trial NCT05087303?
The interventions under investigation include: Types of Telemedicine Delivery Models (OTHER).
Who is sponsoring clinical trial NCT05087303?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05087303 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05087303's enrollment target sits among peer trials
24 15th of 17 higher than 3 of 17 other Anemia, Sickle Cell trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Sickle Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
-
Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
COMPLETED · NA
-
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
COMPLETED · NA
-
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease
COMPLETED · NA
-
MBSR for Pain Catastrophizing in SCD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI